Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BD’s Sharp Thinking: Transition From Traditional Needle-Bearing Devices

This article was originally published in The Gray Sheet

Executive Summary

Becton Dickinson's decision to discontinue sales of its conventional Insyte IV catheters beginning in September is indicative of a trend away from standard needle-bearing offerings in the U.S. in favor of safety-engineered designs

You may also be interested in...



Abbott Retracts Needle-Bearing Devices, Sticks Bar Codes On I.V. Solutions

Abbott is working to convert customers of its standard reseal line of I.V. sets to needleless alternatives to help prevent needlesticks as part of a broader, two-pronged safety initiative outlined March 27

FDA Considers Needlestick Safety Standards For Banning Devices

FDA is soliciting public comment on safety criteria to determine whether to ban certain needlestick devices and create standards aimed at reducing injury risk among health care workers

Bloodborne pathogens

Occupational Health and Safety Administration issues directive Nov. 28 for enforcing bloodborne pathogens standard that was revised in January following passage of the Needlestick Safety and Prevention Act of 2000, which directed employers to choose safer needle devices (1"The Gray Sheet" Jan. 22, 2001, p. 24). OSHA notes that although the agency does not advocate one medical device in all instances, "ideally, the most effective way of removing the hazard of a contaminated needle is to eliminate the needle completely by converting to needleless systems"...

Related Content

UsernamePublicRestriction

Register

MT018219

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel